Cardiac Troponin I Concentration May Predict Mortality
THURSDAY, Aug. 10, 2023 (HealthDay News) -- Cardiac troponin I (cTnI) concentration is associated with medium-term mortality in an unselected hospital population, according to a study published online Aug. 7 in Heart.
Jonathan Hinton, from the University of Southampton in the United Kingdom, and colleagues conducted a prospective observational study including 20,000 consecutive in-hospital and outpatient patients who had a blood test for any reason at a large teaching hospital and in whom a high-sensitivity cTnI assay was measured.
Overall, 91.4 percent of the patients did not have a clinical indication for cTnI testing. The researchers found that 14.1 percent of patients died at a median of 809 days. If the cTnI concentration was above the upper limit of normal, mortality was significantly higher (45.3 versus 12.3 percent). In a multivariable analysis, log10 cTnI concentration was independently associated with mortality (hazard ratio, 1.76). The relationship persisted in a landmark analysis, excluding deaths within 30 days.
"These findings suggest that a snapshot cTn in a hospital population may represent a biomarker of overall medium-term mortality," the authors write.
One author disclosed ties to the biopharmaceutical industry.
Related Posts
Marijuana Can Affect Fetal Development, Even If Used Early in Pregnancy
TUESDAY, May 16, 2023 (HealthDay News) -- As recreational marijuana use rises,...
Scientists Discover Cause of Swallowing Disorder in German Shepherds
MONDAY, March 14, 2022 (HealthDay News) -- German shepherds are one of the most...
Un experto responde tus preguntas sobre el cáncer de próstata
MARTES, 5 de septiembre de 2023 (Noticias HealthDay) -- Es fundamental que los...
Model Targeting Appetitive Traits Aids Weight Loss
WEDNESDAY, May 25, 2022 (HealthDay News) -- A novel intervention targeting...